Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 6. Click on ID to see further detail.
IDOV_3627Virus nameMeasles virusVirus strainwild typeVirus genome typeRNAVirus familyParamyxoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman gastric cancer cell lineCell lineKATO IIIConcentration of cell line5000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 MOIIn-vitro result90% cell viability after day 3Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedVirus in combination with induce apiptosis in cancer cellImmunogenic effectNAClinical trialNAPMID29485292
IDOV_3628Virus nameMeasles virusVirus strainwild typeVirus genome typeRNAVirus familyParamyxoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman gastric cancer cell lineCell lineKATO IIIConcentration of cell line5000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 MOIIn-vitro result60% cell viability after day 6Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedVirus in combination with induce apiptosis in cancer cellImmunogenic effectNAClinical trialNAPMID29485292
IDOV_3641Virus nameMumps virusVirus strainwild typeVirus genome typeRNAVirus familyParamyxoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman gastric cancer cell lineCell lineKATO IIIConcentration of cell line5000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 MOIIn-vitro result70% cell viability after day 3Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedVirus in combination with induce apiptosis in cancer cellImmunogenic effectNAClinical trialNAPMID29485292
IDOV_3642Virus nameMumps virusVirus strainwild typeVirus genome typeRNAVirus familyParamyxoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman gastric cancer cell lineCell lineKATO IIIConcentration of cell line5000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 MOIIn-vitro result30% cell viability after day 6Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedVirus in combination with induce apiptosis in cancer cellImmunogenic effectNAClinical trialNAPMID29485292
IDOV_3655Virus nameMeasles and mumps virusVirus strainwild typeVirus genome typeRNAVirus familyParamyxoviridaeVirus genome modificationNoneVirus aloneNoVirus in combination with drug/radiationMeasles virus in combination with mumps virusImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman gastric cancer cell lineCell lineKATO IIIConcentration of cell line5000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 MOIIn-vitro result70% cell viability after day 3Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedVirus in combination with induce apiptosis in cancer cellImmunogenic effectNAClinical trialNAPMID29485292
IDOV_3656Virus nameMeasles and mumps virusVirus strainwild typeVirus genome typeRNAVirus familyParamyxoviridaeVirus genome modificationNoneVirus aloneNoVirus in combination with drug/radiationMeasles virus in combination with mumps virusImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman gastric cancer cell lineCell lineKATO IIIConcentration of cell line5000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 MOIIn-vitro result20% cell viability after day 6Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedVirus in combination with induce apiptosis in cancer cellImmunogenic effectNAClinical trialNAPMID29485292